| Title |
|
|
|
Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC) : a double-blind, randomised, phase 3 trial
| |
| Author |
|
|
|
| |
| Abstract |
|
|
| | |
| Language |
|
|
|
English
| |
| Source (journal) |
|
|
|
The lancet oncology. - London | |
| Publication |
|
|
|
London : 2010
| |
| ISSN |
|
|
|
1470-2045
| |
| Volume/pages |
|
|
|
11:7(2010), p. 619-626
| |
| ISI |
|
|
|
000279860300015
| |
| Full text (Publisher's DOI) |
|
|
| | |
|